期刊文献+
共找到3,805篇文章
< 1 2 191 >
每页显示 20 50 100
复发难治性弥漫大B细胞淋巴瘤靶向免疫治疗的研究进展
1
作者 李春梅 张清媛 《现代肿瘤医学》 2026年第1期152-158,共7页
在非霍奇金淋巴瘤(non-Hodgkin's lymphoma,NHL)中,弥漫大B细胞淋巴瘤(diffuse large B cell lymphoma,DLBCL)的发生率最高,其异质性明显。利妥昔单抗的出现极大改善了患者的预后及生存,其联合CHOP成为经典一线治疗方案,50%~70%患... 在非霍奇金淋巴瘤(non-Hodgkin's lymphoma,NHL)中,弥漫大B细胞淋巴瘤(diffuse large B cell lymphoma,DLBCL)的发生率最高,其异质性明显。利妥昔单抗的出现极大改善了患者的预后及生存,其联合CHOP成为经典一线治疗方案,50%~70%患者可治愈,但仍有30%~50%因耐药等原因反应差或在缓解后复发。复发难治DLBCL,尤其是无法自体造血干细胞移植或移植后复发病人的治疗是目前亟待解决的问题。随着对靶向免疫治疗研究的不断深入,许多药物不断进入临床应用或正在开发中,该文主要就单克隆抗体、双特异性抗体、抗体药物偶联物、选择性核出口蛋白抑制剂、嵌合抗原受体T细胞、程序性死亡受体/配体1抑制剂等药物作一简要综述。 展开更多
关键词 弥漫大B细胞淋巴瘤 复发 难治 靶向治疗 免疫治疗
暂未订购
子宫内膜息肉组织中COX-2、Pten、Pax2蛋白表达情况及其与患者术后早期复发的关系
2
作者 张海燕 李红 +2 位作者 房秋霞 吴聪哲 白惠 《检验医学与临床》 2026年第1期57-62,共6页
目的探讨子宫内膜息肉(EP)患者组织中环氧合酶(COX)-2、磷酸酶与张力蛋白同源物基因(Pten)、配对盒基因(Pax)2蛋白表达情况及其与患者术后早期复发的关系。方法选取2021年1月至2023年10月该院收治的187例EP患者作为研究对象,入院后采集... 目的探讨子宫内膜息肉(EP)患者组织中环氧合酶(COX)-2、磷酸酶与张力蛋白同源物基因(Pten)、配对盒基因(Pax)2蛋白表达情况及其与患者术后早期复发的关系。方法选取2021年1月至2023年10月该院收治的187例EP患者作为研究对象,入院后采集其息肉和息肉旁正常组织,采用免疫组织化学法检测组织中COX-2、Pten、Pax2蛋白表达情况。对EP患者术后随访6个月,根据术后早期是否复发将EP患者分为复发组和未复发组。采用多因素Logistic回归分析EP患者术后早期复发的影响因素。结果EP患者息肉组织中COX-2蛋白表达阳性率高于息肉旁正常组织,Pten、Pax2蛋白表达阳性率均低于息肉旁正常组织,差异均有统计学意义(P<0.05)。体质量指数(BMI)>24 kg/m^(2)的EP患者息肉组织中COX-2蛋白表达阳性率高于BMI≤24 kg/m^(2)的EP患者,息肉组织中Pten、Pax2蛋白表达阳性率均低于BMI≤24 kg/m^(2)的EP患者,差异均有统计学意义(P<0.05)。复发组47例,未复发组140例。复发组BMI>24 kg/m^(2)占比、息肉组织中COX-2蛋白表达阳性率均高于未复发组,Pten、Pax2蛋白表达阳性率均低于未复发组,差异均有统计学意义(P<0.05)。多因素Logistic回归分析结果显示,BMI>24 kg/m^(2)、息肉组织中COX-2蛋白表达阳性及Pten、Pax2蛋白表达阴性均为EP患者术后早期复发的危险因素(P<0.05)。结论EP患者息肉组织中COX-2蛋白表达阳性率高于息肉旁正常组织,Pten、Pax2蛋白表达阳性率均低于息肉旁正常组织,与患者及术后早期复发均有关。 展开更多
关键词 子宫内膜息肉 环氧合酶-2 磷酸酶与张力蛋白同源物基因 配对盒基因2 临床参数 复发
暂未订购
复发/难治性多发性骨髓瘤的药物治疗研究进展
3
作者 刘廷雨(综述) 熊杰(审校) 张燕(审校) 《疑难病杂志》 2026年第1期111-115,共5页
复发/难治性多发性骨髓瘤(RRMM)是目前临床治疗的难点,其疾病异质性与耐药机制导致患者预后不佳。近年来,该病治疗策略正经历从传统化疗到靶向与免疫治疗的范式转移。文章系统综述了RRMM的药物治疗进展:一方面,蛋白酶体抑制剂、免疫调... 复发/难治性多发性骨髓瘤(RRMM)是目前临床治疗的难点,其疾病异质性与耐药机制导致患者预后不佳。近年来,该病治疗策略正经历从传统化疗到靶向与免疫治疗的范式转移。文章系统综述了RRMM的药物治疗进展:一方面,蛋白酶体抑制剂、免疫调节剂等传统靶向药物通过迭代优化持续突破疗效瓶颈;另一方面,以单克隆抗体、抗体药物偶合物、双特异性抗体及嵌合抗原受体T细胞(CAR-T)疗法为代表的免疫治疗,为多重耐药患者带来了深度且持久的缓解。未来RRMM的临床管理将迈向以生物标志物为导向的精准化、个体化全程治疗,并通过机制驱动的联合策略与治疗关口前移,最终将其转变为一种可长期控制的慢性疾病。 展开更多
关键词 复发/难治性多发性骨髓瘤 靶向药物 免疫疗法 联合治疗
暂未订购
The treatment of relapsing primary nephrotic syndrome in children 被引量:6
4
作者 王亚萍 刘爱民 +2 位作者 戴宇文 杨诚 汤宏峰 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2005年第7期682-685,共4页
Objective: To explore better therapy and reduce the rate of re-relapse of primary nephritic syndrome in children who had been treated with corticosteroids but relapsed. Methods: Eighty relapsers were enrolled from Jan... Objective: To explore better therapy and reduce the rate of re-relapse of primary nephritic syndrome in children who had been treated with corticosteroids but relapsed. Methods: Eighty relapsers were enrolled from Jan. 1994 to Apr. 2000, who were randomly divided into two groups. The treatment group (n=39) had been treated with tripterysium glucosides for three months,with the control group (n=41) members were treated with cyclophosphmide (CTX) by intermission intravenous pulse, with total dose of CTX not being more than 150 mg/kg. Prednisone, meanwhile, was given to both groups. The total treatment period of prednisone was prolonged by 12-18 months. Results: After following up for 3-7 years, the re-relapse rates of both groups were observed. The re-relapse rate of the treatment group was 28.2% to 29.3% in the CTX-controlled group. The re-relapse rates between two groups were almost similar, and with no observed significant difference (P>0.05). The side effect of tripterysium glucosides was less than that of CTX. Conclusion: For the treatment of relapsing nephritic syndrome in children, the combination of tripterysium glucosides and prolonged corticosteroid therapy is as effective as the regimen of CTX plus prolonged use of prednisone. 展开更多
关键词 Primary nephrotic syndrome RELAPSE Tripterysium glucosides PREDNISONE
暂未订购
Diagnosis and management of relapsing pancreatitis associated with cystic neoplasms of the pancreas 被引量:2
5
作者 William R Brugge 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第7期1038-1043,共6页
One of the most important causes of relapsing pancreatitis is a cystic neoplasm of the pancreas. These low grade malignancies may cause pancreatitis by obstructing or communicating with a pancreatic duct. Patients wit... One of the most important causes of relapsing pancreatitis is a cystic neoplasm of the pancreas. These low grade malignancies may cause pancreatitis by obstructing or communicating with a pancreatic duct. Patients with relapsing pancreatitis and a focal fluid fluid collection should be investigated for the possibility of a mucinous cystic neoplasm. Cross sectional imaging can provide a diagnosis with the imaging findings of a low attenuation cystic lesion containing mural calcification (CT scanning) or a lobular T2 enhancing lesion (MRCP). Endoscopic ultrasound can provide more detailed imaging with the ability to guide fine needle aspiration of the cyst fluid. Cyst fluid analysis can provide a diagnosis of a mucinous cystic lesion with the combination of cytology (mucinous epithelium), elevated carcinoembryonic antigen (CEA), and the presence of DNA mutations. Management of these patients consists of surgical resection and monitoring in patients not able to withstand surgery. 展开更多
关键词 PANCREATITIS relapsing pancreatitis Endoscopic ultrasound Cystic neoplasms Intraductal papillary mucinous neoplasms Fine needle aspiration
暂未订购
肝细胞癌患者肝切除术后1个月外周血RBM15 mRNA及血清GDF-15蛋白变化率对术后复发的预测价值
6
作者 吴中立 罗超 杨涌 《检验医学与临床》 2026年第1期7-12,19,共7页
目的探讨肝细胞癌(HCC)患者肝切除术后1个月外周血核糖核酸结合蛋白15(RBM15)mRNA及血清生长分化因子-15(GDF-15)蛋白变化率对术后复发的预测价值。方法选取2018年1月至2022年6月四川省成都市双流区第一人民医院收治的200例HCC患者作为... 目的探讨肝细胞癌(HCC)患者肝切除术后1个月外周血核糖核酸结合蛋白15(RBM15)mRNA及血清生长分化因子-15(GDF-15)蛋白变化率对术后复发的预测价值。方法选取2018年1月至2022年6月四川省成都市双流区第一人民医院收治的200例HCC患者作为研究对象。根据HCC患者肝切除术后复发情况分为复发组和未复发组,比较2组基线资料以及术前、术后1个月外周血RBM15 mRNA和血清GDF-15蛋白水平;计算及比较2组外周血RBM15 mRNA、血清GDF-15蛋白变化率。采用多因素Logistic回归分析HCC患者肝切除术后复发的影响因素。绘制受试者工作特征(ROC)曲线分析外周血RBM15 mRNA和血清GDF-15蛋白变化率对HCC患者肝切除术后复发的预测价值,并进行5折交叉验证。结果随访截止时间为2024年12月30日,随访期间共有9例失访,70例发生复发。复发组血清甲胎蛋白(AFP)水平及肿瘤分化程度(中低)、癌灶数量(多发)、合并糖尿病所占比例均高于未复发组,差异均有统计学意义(P<0.05)。复发组术前、术后1个月外周血RBM15 mRNA和血清GDF-15蛋白水平均高于未复发组,外周血RBM15 mRNA和血清GDF-15蛋白变化率均低于未复发组,差异均有统计学意义(P<0.05)。在校正AFP、肿瘤分化程度、癌灶数量、合并糖尿病因素后,术后1个月外周血RBM15 mRNA、血清GDF-15蛋白变化率升高均是HCC患者肝切除术后复发的保护因素(P<0.05)。术后1个月外周血RBM15 mRNA、血清GDF-15蛋白变化率联合预测HCC患者肝切除术后复发的曲线下面积(AUC)为0.866,大于二者单独预测的AUC(0.766、0.774),差异均有统计学意义(Z=2.138、2.174,P=0.033、0.030),且经过5折交叉验证,外周血RBM15 mRNA、血清GDF-15蛋白变化率联合预测HCC患者肝切除术后复发的正确率为80.63%。结论术后1个月外周血RBM15 mRNA、血清GDF-15蛋白变化率是HCC患者肝切除术后复发的影响因素,二者联合对HCC患者肝切除术后复发的预测价值较高,有利于制订合理的治疗措施,降低术后复发风险。 展开更多
关键词 肝细胞癌 肝切除术 复发 核糖核酸结合蛋白15 生长分化因子-15
暂未订购
Relapsing polychondritis with p-ANCA associated vasculitis: Which triggers the other? 被引量:1
7
作者 Ibolya File Csilla Trinn +3 位作者 Zsolt Mátyus László Ujhelyi József Balla János Mátyus 《World Journal of Clinical Cases》 SCIE 2014年第12期912-917,共6页
Relapsing polychondritis(RP) is a rare autoimmune disease with chronic inflammatory/destructive lesions of the cartilaginous tissues. In one third of the cases it is associated with other autoimmune disorders, mostly ... Relapsing polychondritis(RP) is a rare autoimmune disease with chronic inflammatory/destructive lesions of the cartilaginous tissues. In one third of the cases it is associated with other autoimmune disorders, mostly with anti-neutrophil cytoplasmic antibody(ANCA) associated vasculitis(AAV). We report three cases of RP with p-ANCA positive AAV. In the first patient RP developed 1.5 years after the onset of AAV. In the others the signs of RP were present before the onset of severe crescent glomerulonephritis. Patients responded well on steroid and cyclophosphamide. In dialysis dependent cases plasmapheresis was also used successfully. During the 2 and 1.5 years of follow up, they were symptom-free, and had stable glomerular filtration rate. The first patient died after four years of follow-up due to the complications of sudden unset pancytopenia,which raises the possibility of associated hemophagocytic syndrome. In the setting of RP or AAV physicians should always be aware of the possibility of sudden or insidious appearance of the other disease. 展开更多
关键词 relapsing POLYCHONDRITIS Anti-neutrophil CYTOPLASMIC ANTIBODY Anti-neutrophil CYTOPLASMIC antibody-associated vasculitis Rapidly progressive GLOMERULONEPHRITIS Immunosuppressive treatment
暂未订购
Immunomodulatory activity of berberine in alleviating experimental chronic relapsing colitis via inhibition of the JAK/STAT signalling
8
《中国药理学通报》 CAS CSCD 北大核心 2015年第B11期50-51,共2页
Aim Ulcerative colitis (UC) is an increasingly common condition particularly in developed countries. The lack of satisfactory treatment fuels the search for alternative therapeutic strategies. In the present study, ... Aim Ulcerative colitis (UC) is an increasingly common condition particularly in developed countries. The lack of satisfactory treatment fuels the search for alternative therapeutic strategies. In the present study, we as- sessed the preclinical activity of berberine for the treatment of dextran sodium sulphate (DSS)-induced chronic re- lapsing colitis in C57BL/6 mice. Methods Colitis of mice was induced by three cycles of 2.0% DSS. From day13 onward, colitis mice were orally administered with 20 mg/kg berberine for 30 days. The disease severity was de- termined by daily monitoring the body weight, stool consistency, and stool bleeding of mice. At the end of treat- ment, colons were collected and subjected to histological, RT-qPCR, Western blot, and LC-MS analyses. Lympho- eytes were isolated from spleens and cultured for assessment of eytokine secretion. Results Berberine significantly ameliorated disease severity, colon shortening, histological injuries of colitis mice. Further, berberine treatment consistently and notably regulated DSS-assoeiated increase in mRNAs levels of Thl7-related eytokines (inhibition of IL-17 and ROR-γt) in the colon out of all tested eytokines. Moreover, the increases of TNF-α, IL-6 and IL-23 mRNA, and the phosphorylated STAT3 in colons of DSS - treated mice were significantly reversed by berberine. In addition, berberine directly inhibited TNF-α and IL-17 secretion from cultured lymphoeytes upon PMA/ionomyein -1 re-stimulation. In the meanwhile, a six-time amount of berberine in colon tissue (4.26 ± 2.62 ng · g^-1 colon) was measured when compared that in serum (0.76 ± 0.23 ng · m1^-1) and no detected histological changes was found in major organs of colitis mice. Conclusion We demonstrate for the first time that berberine exerts immuno- modulatory effect in alleviating DSS-indueed chronic relapsing colitis via inhibition of the JAK/STAT signalling acti- vation in the inflamed colon. The demonstration of activity in this model supports the possibility of clinical efficacy of berberine in treating chronic UC. 展开更多
关键词 BERBERINE DSS CHRONIC relapsing COLITIS JAIL/STAT signaling
暂未订购
Eustachian tube involvement in a patient with relapsing polychondritis detected by magnetic resonance imaging:A case report
9
作者 Daisuke Yunaiyama Akiko Aoki +3 位作者 Hiroshi Kobayashi Miwako Someya Mitsuru Okubo Kazuhiro Saito 《World Journal of Clinical Cases》 SCIE 2022年第4期1441-1446,共6页
BACKGROUND Relapsing polychondritis(RP)is a rare inflammatory disease involving the systemic cartilage,such as the auricle,trachea,and bronchiole,among others.A patient with RP shows variable symptoms based on the inv... BACKGROUND Relapsing polychondritis(RP)is a rare inflammatory disease involving the systemic cartilage,such as the auricle,trachea,and bronchiole,among others.A patient with RP shows variable symptoms based on the involved cartilage.CASE SUMMARY A 72-year-old Japanese woman with a history of redness of the bilateral auricles for 3 d was referred to a clinician.The clinician prescribed antibiotics to the patient;however,the symptoms worsened;thus,she was referred to our hospital.Head and neck magnetic resonance imaging(MRI)showed edematous auricle with remarkable contrast,fluid collection in the bilateral mastoid cells,suggesting otitis media.The eustachian tube(ET)on the right side was also edematous with contrast enhancement.The patient was suspected of RP according to the diagnostic criteria.A biopsy of the auricular cartilage was performed by an otorhinolaryngologist,confirming pathological proof of RP.Treatments with steroids were immediately administered thereafter.CONCLUSION We highlight a rare case of RP with radiologically confirmed involvement of ET in the MRI. 展开更多
关键词 relapsing polychondritis Magnetic resonance imaging Contrast enhancement Otitis media with effusion Eustachian tube Case report
暂未订购
Relapsing polychondritis causing breathlessness: Two case reports
10
作者 Song-Yu Zhai Yu-Hao Zhang +2 位作者 Ru-Yan Guo Jie-Wen Hao Shu-Xin Wen 《World Journal of Clinical Cases》 SCIE 2022年第23期8360-8366,共7页
BACKGROUND Relapsing polychondritis is a rare multisystem autoimmune disease that mainly involves systemic cartilage and proteoglycan-rich tissues.If the larynx and trachea are involved,the patient’s condition deteri... BACKGROUND Relapsing polychondritis is a rare multisystem autoimmune disease that mainly involves systemic cartilage and proteoglycan-rich tissues.If the larynx and trachea are involved,the patient’s condition deteriorates rapidly.When relapsing polychondritis becomes more advanced,the airways collapse and treatment is difficult,rendering a poor prognosis.Therefore,the diagnosis method,treatment strategy and prognosis of relapsing polychondritis with larynx and trachea involvement need to be elucidated to improve clinicians’awareness of the disease.CASE SUMMARY A man and a woman were admitted because of breathlessness.Relapsing polychondritis was diagnosed after a series of accessory examinations.They were both treated with glucocorticoids and immunosuppressants,and underwent tracheotomy as their breathing difficulties could not be relieved by the medication.CONCLUSION The two cases highlight the importance of the timely diagnosis,full evaluation and initiating individualized treatment of relapsing polychondritis with larynx and trachea involvement.Laryngoscopy,bronchoscopy and pathological examination are helpful in diagnosis of this disease. 展开更多
关键词 relapsing polychondritis LARYNX TRACHEA Case report
暂未订购
Relapsing polychondritis with isolated tracheobronchial involvement complicated with Sjogren's syndrome:A case report
11
作者 Jun-Yan Chen Xiao-Yan Li Chen Zong 《World Journal of Clinical Cases》 SCIE 2022年第19期6563-6570,共8页
BACKGROUNDRelapsing polychondritis (RP) is a rare, long-term, and potentially life-threateningdisease characterised by recurrent paroxysmal inflammation that can involve anddestroy the cartilage of the external ear, n... BACKGROUNDRelapsing polychondritis (RP) is a rare, long-term, and potentially life-threateningdisease characterised by recurrent paroxysmal inflammation that can involve anddestroy the cartilage of the external ear, nose, larynx, and trachea.CASE SUMMARYWe here report a case of RP involving solely the tracheobronchial cartilage ring(and not the auricular. nasal or articular cartilage) complicated by Sjögren's syndrome in a 47-year-old female whose delayed diagnosis caused a sharpdecline in pulmonary function. After corticosteroid treatment, her pulmonaryfunction improved.CONCLUSIONIn such cases, our experience suggested that 18F-fluorodeoxyglucose positronemission tomography/computed tomography (18F-FDG PET/CT) and fiberopticbronchoscopy should be used to diagnose airway chondritis as relapsing polychondritisin the early phase of disease. 展开更多
关键词 relapsing polychondritis Tracheobronchial involvement 18F-fluorodeoxyglucose positron emission tomography/computed tomography Fiberoptic bronchoscopy Case report
暂未订购
Relapsing Polychondritis Associated with Myelodysplastic Syndrome
12
作者 Mahfoudhi Madiha Mamlouk Habiba +2 位作者 Lahiani Rym Turki Sami Kheder Adel 《Open Journal of Clinical Diagnostics》 2015年第1期10-13,共4页
A 62-year-old man had arthritis and an infiltrated purpuric eruption of the legs. He presented then a cyanosis and aches of the left ear’s pinna with a voice disturbance and an inflammatory aspect of the nose. He had... A 62-year-old man had arthritis and an infiltrated purpuric eruption of the legs. He presented then a cyanosis and aches of the left ear’s pinna with a voice disturbance and an inflammatory aspect of the nose. He had an anemia and a thrombopenia. The infectious and auto-immune research was negative. The laryngo-tracheal scan revealed calcifications of the larynx, the trachea and the initial portion of bronchi. Moreover, the biopsy from ear’s pinna cartilage confirmed the diagnosis of chondritis and peri-chondritis. He was thus considered to have the association with relapsing polychondritis and a myelodysplastic syndrome. The patient was treated with corticosteroids and iterative transfusions. The articular and skinny patient’s symptoms completely resolved. The anemia and the thrombopenia were partially improved. The relapsing polychondritis can be considered as paraneoplastic complication in the context of a myelodysplastic syndrome or as a fortuitous association. The mechanism of such an association remains unknown. 展开更多
关键词 relapsing Polychodritis BIOPSY MYELODYSPLASTIC SYNDROME PROGNOSIS
暂未订购
Hemophagocytic lymphohistiocytosis triggered by relapsing polychondritis:A case report
13
作者 Mi-Ran Han Jeong-Hwan Hwang +4 位作者 Seungah Cha So-Yeon Jeon Kyu Yun Jang Namsu Kim Chang-Hoon Lee 《World Journal of Orthopedics》 2024年第8期813-819,共7页
BACKGROUND Hemophagocytic lymphohistiocytosis(HLH)is a rare,life-threatening disorder caused by abnormal histiocytes and T cell activation.In adults,it is predominantly associated with infections,cancers,and autoimmun... BACKGROUND Hemophagocytic lymphohistiocytosis(HLH)is a rare,life-threatening disorder caused by abnormal histiocytes and T cell activation.In adults,it is predominantly associated with infections,cancers,and autoimmune diseases.Relapsing polychondritis(RP),another rare disease,is diagnosed based on symptoms without specific tests,featuring cartilage inflammation characterized by swelling,redness,and pain,rarely inducing HLH.CASE SUMMARY A 74-year-old woman visited the emergency room with a fever of 38.6℃.Blood tests,cultures,and imaging were performed to evaluate fever.Results showed increased fluorescent antinuclear antibody levels and mild cytopenia,with no other specific findings.Imaging revealed lymph node enlargement was observed;however,biopsy results were inconclusive.Upon re-evaluation of the physical exam,inflammatory signs suggestive of RP were observed in the ears and nose,prompting a tissue biopsy for confirmation.Simultaneously,persistent fever accompanied by cytopenia prompted a bone marrow examination,revealing hemophagocytic cells.After finding no significant results in blood culture,viral markers,and tissue examination of enlarged lymph nodes,HLH was diagnosed by RP.Treatment involved methylprednisolone followed by azathioprine.After two months,bone marrow examination confirmed resolution of hemophagocytosis,with normalization of hyperferritinemia and pancytopenia.CONCLUSION Thorough physical examination enabled diagnosis and treatment of HLH trig gered by RP in patients presenting with fever of unknown origin. 展开更多
关键词 Hemophagocytic lymphohistiocytosis relapsing polychondritis Autoimmune disease Fever of unknown origin STEROID Case report
暂未订购
Impact of an Exercise Training Program in a Patient with Relapsing Polychondritis: A Case Report
14
作者 Alexandre Moura dos Santos Diego Sales de Oliveira +5 位作者 Rafael Giovani Misse Letícia Alves Perin Jean Marcos de Souza Fernanda Rodrigues Lima Rosa Maria Rodrigues Pereira Samuel Katsuyuki Shinjo 《Open Journal of Rheumatology and Autoimmune Diseases》 2018年第3期93-98,共6页
Background: Exercise training has demonstrating to be safe and promote benefits for several rheumatologic autoimmune diseases. However, no study has evaluated the safety and benefits of exercise in relapsing polychond... Background: Exercise training has demonstrating to be safe and promote benefits for several rheumatologic autoimmune diseases. However, no study has evaluated the safety and benefits of exercise in relapsing polychondritis. Aim: To evaluate the effectiveness of an exercise training program in a patient with relapsing polychondritis. Case presentation: A 67-year-old female patient with relapsing polychondritis in remission was submitted to a 12-week, twice weekly, aerobic and resistance training program. Aerobic capacity, muscle strength and function capacity, as well as body composition, were evaluated at baseline and after 12-weeks. Conclusions: Exercise training program demonstrated to be effective for increasing aerobic capacity, muscle strength and function, and for improving body composition in the patient. Further studies are necessary to confirm these findings. 展开更多
关键词 EXERCISE TRAINING relapsing POLYCHONDRITIS AEROBIC TRAINING Resistance TRAINING
暂未订购
Stenosis of the Subglottic Trachea Revealing Relapsing Polychondritis of a Young Adult
15
作者 Mounira El Euch Madiha Mahfoudhi +5 位作者 Imen Gorsane Souha Hadded Wifek Bani Moez Karoui Sami Turki Taieb Ben Abdallah 《International Journal of Clinical Medicine》 2015年第9期646-651,共6页
Relapsing polychondritis is a rare inflammatory disease involving essentially cartilaginous structures. Other systemic manifestations can be encountered as the eye and ear disturbance. Aortic aneurysms affect few case... Relapsing polychondritis is a rare inflammatory disease involving essentially cartilaginous structures. Other systemic manifestations can be encountered as the eye and ear disturbance. Aortic aneurysms affect few cases. If affection of airway cartilages occurs, prognosis may be worsened by eventual stenotic lesions. We report a 22-year-old woman with Relapsing polychondritis. When she was referred to our hospital 4 weeks after the onset of respiratory symptoms, she was having severe breathing difficulty. Immediate tracheostomy followed by steroid therapy improved her respiratory condition, although the treatment was complicated because of her diabetes. While airway involvement of Relapsing polychondritis can be life threatening, it is curable with steroid therapy. Clinicians should keep in mind that airway obstruction could be caused by this disease. 展开更多
关键词 relapsing POLYCHONDRITIS Airway NARROWING Prognosis
暂未订购
Larngeal Manifestations of Relapsing Polychondritis
16
作者 Abdul Latif Hamdan Doja Sarieddine 《Open Journal of Rheumatology and Autoimmune Diseases》 2013年第2期108-112,共5页
The incidence of Relapsing Polychondritis is estimated to be 3.5 cases per million with only 600 cases being reported in the world. It can affect any age ranging from 5 to 84 years with predominance in the fourth and ... The incidence of Relapsing Polychondritis is estimated to be 3.5 cases per million with only 600 cases being reported in the world. It can affect any age ranging from 5 to 84 years with predominance in the fourth and fifth decade. Male to female ratio varies from 1:1 to 1:3. It is believed to be an immunologic reaction to collagen Type II which is predominantly presented in the cartilaginous structures of the body and in the eye. The diagnosis is based on the presence of three or more clinical signs, one clinical sign in addition to histological confirmation, or involvement of two or more sites with a favorable response to treatment based on Mc Adam diagnostic criteria. The otolaryngologic manifestations of RP span the ears, nose, larynx and tracheobronchial tree. The symptoms include change in voice quality, respiratory discomfort, stridor, dyspnea, cough, chocking, anterior neck tenderness mainly over the thyroid cartilage and cricoid cartilages, aspiration and difficulty in swallowing. The laryngeal manifestations should be evaluated using high resolution computerized tomography, Magnetic resonance imaging, pulmonary function testing, plain radiography and pulmonary function testing. 展开更多
关键词 relapsing POLYCHONDRITIS LARYNX STRIDOR
暂未订购
A Case of Relapsing Polychondritis Successfully Treated with Combination of a Glucocorticoid and Cyclosporine
17
作者 Koichiro Takahashi Hiroshi Inoue +3 位作者 Hironori Sadamatsu Hitomi Umeguchi Naoko Sueoka-Aragane Shinya Kimura 《International Journal of Clinical Medicine》 2015年第7期439-443,共5页
Relapsing polychondritis is a rare cartilaginous inflammatory disease affecting the external ear, nose, peripheral joints and tracheobronchial tree. It is characterized by recurrent inflammation and degeneration of ca... Relapsing polychondritis is a rare cartilaginous inflammatory disease affecting the external ear, nose, peripheral joints and tracheobronchial tree. It is characterized by recurrent inflammation and degeneration of cartilage and connective tissue. A 72-year-old man complained of dyspnea, cough and wheezing for 2 months. Diffuse wall thickening and narrowing from the trachea to segmental bronchus were seen on chest CT. Tracheostomy was performed in order to avoid as-phyxia, and he was diagnosed as relapsing polychondritis on the basis of pathology evaluation of a tracheal biopsy specimen. He was treated with high doses of a glucocorticoid, with which his symptoms improved. However, the cough and wheezing recurred after tapering of the glucocorticoid. His symptoms thereafter were improved by combination of the glucocorticoid with cyclosporine. The immunosuppressive agent provided effective treatment for glucocorticoid-resistant relapsing polychondritis. 展开更多
关键词 relapsing POLYCHONDRITIS TRACHEA CYCLOSPORINE
暂未订购
Uncharted Territory: Frequent Relapsing, Steroid Sensitive Secondary Minimal Change Nephrotic Syndrome Cause by Solid Tumor of the Gastro-Esophageal Junction —(Case Presentation and Review of the Literature)
18
作者 Awad Magbri Mariam El-Magbri +1 位作者 Reshma Shamnarine Pablo Abrego Hernandez 《Open Journal of Nephrology》 CAS 2023年第1期13-19,共7页
We reported a biopsy proved case of minimal change nephrotic syndrome in a 72-year-old patient. The minimal change nephrotic syndrome has been steroid sensitive, but the patient had 7 relapses over a span of 5 years. ... We reported a biopsy proved case of minimal change nephrotic syndrome in a 72-year-old patient. The minimal change nephrotic syndrome has been steroid sensitive, but the patient had 7 relapses over a span of 5 years. Each time the dose of steroid is tapered, a relapse of the nephrotic syndrome occurred. Eventually, the patient was complaining of dysphagia and difficulty swallowing. Hospital work-up with barium swallow, endoscopy, and CT of the chest, abdomen and pelvis, revealed a focal stenotic lesion with mild to moderate esophageal dysmotility 7/15/2022. A diagnosis of an ulcerating lesion with biopsy confirmed a neuro-endocrine carcinoma of the gastro-esophageal junction was entertained. The CT of the chest/abdomen/pelvis, 7/19/2022, has shown, an esophageal mass of 5.1 × 5.6 × 7 cm of the gastro-esophageal junction with ulceration. No evidence of spread beyond the esophagus and stomach. The histology revealed a poorly differentiated neuroendocrine tumor of the gastro-esophageal junction. The patient underwent several rounds of chemotherapy, radiation, and surgery culminating in tumor control. His nephrotic syndrome was resolved after the tumor has been controlled by surgery and chemotherapy. 展开更多
关键词 Frequent relapsing Nephrotic Syndrome Steroid Sensitive Nephrotic Syndrome Secondary Nephrotic Syndrome Solid Gastro-Intestinal Tumor Minimal Change Nephrotic Syndrome Neuro-Endocrine Tumor of the Gastro-Esophageal Junction Paraneoplastic Glomerulopathy
暂未订购
Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis
19
作者 Stefan Lukac Terezia Kalnovicova Jana Muchova 《Health》 2013年第11期1924-1928,共5页
Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system (CNS) through demyelination and neurodegeneration. Several lines of evidence support a role for oxidative and nitrative str... Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system (CNS) through demyelination and neurodegeneration. Several lines of evidence support a role for oxidative and nitrative stress (OS and NS) in pathogenesis of multiple sclerosis. The mechanism of influence of OS and NS on blood-brainbarrier (BBB) has critical importance for evaluating antioxidant therapies. As far as we know, markers of oxidative and nitrative stress in MS patients have been investigated independently for their relationship with the state of the blood-brain-barrier. Blood plasma samples of 58 patients with relapse-remitting MS (RRMS) with normal (Group A, n = 48, 36.2 ± 10.5 years) and damaged BBB (Group B, n = 10, 38.2 ± 11.2 years) and of 44 healthy controls (39.2 ± 14.9 years) were analyzed. TAS (total antioxidant plasma status), lipoperoxides, protein carbonyls, 3-nitrotyrosine and uric acid were evaluated in each group. Our results confirmed decreased TAS (Group A: 1.35 ± 0.55 mmol/l, P e level of lipoperoxidation positively correlated with the state of BBB (P of protein’s carbonyls (A: 0.48 ± 0.11 nmol/mg protein, P nmol/l, P ed damage to plasma proteins, what was confirmed by their positive mutual correlation (P The level of uric acid was physiological and correlated negatively with protein’s carbonyls (P 0.05) while there was no significant relationship with 3-nitotyrosine. The results suggest the role of this antioxidant in the protection of the proteins against OS what was confirmed by its positive correlation with TAS 展开更多
关键词 relapsing Remiting Multiple Sclerosis Oxidative Stress Nitrative Stress BLOOD-BRAIN-BARRIER Total Antioxidant Status 3-NITROTYROSINE Protein Carbonyls Lipoperoxides Uric Acid
暂未订购
泊马度胺为主方案治疗复发难治性多发性骨髓瘤的临床效果研究 被引量:3
20
作者 杨满 黄琰 +4 位作者 张灵秀 吕国庆 朱璐瑶 刘宪凯 郭燕 《中国实验血液学杂志》 北大核心 2025年第2期431-436,共6页
目的:研究泊马度胺为主方案治疗复发难治性多发性骨髓瘤(RRMM)的临床效果。方法:选取2020年11月至2023年1月新乡医学院第一附属医院血液科收治的RRMM患者60例作为研究对象,其中15例采用PDD方案(泊马度胺+达雷妥尤单抗+地塞米松),45例采... 目的:研究泊马度胺为主方案治疗复发难治性多发性骨髓瘤(RRMM)的临床效果。方法:选取2020年11月至2023年1月新乡医学院第一附属医院血液科收治的RRMM患者60例作为研究对象,其中15例采用PDD方案(泊马度胺+达雷妥尤单抗+地塞米松),45例采用PCD方案(泊马度胺+环磷酰胺+地塞米松),观察并评价临床效果。结果:所有患者中位疗程5(2-11)个,总体反应率(ORR)为75.0%;采用PDD方案的患者ORR为73.3%,采用PCD方案的患者ORR为75.6%。46例非高危细胞遗传学异常患者的ORR为86.9%,显著高于14例高危细胞遗传学异常患者的35.7%(χ^(2)=15.031,P<0.05)。所有患者的中位PFS为8.0(95%CI:6.8-9.1)个月,中位OS为14.0(95%CI:11.3-16.7)个月。PDD方案中非高危细胞遗传学异常患者的PFS和OS均显著高于高危细胞遗传学异常患者[PFS:7.0(95%CI:4.6-9.3)个月vs 4.0(95%CI:3.1-4.8)个月,χ^(2)=5.120,P<0.05;OS:未达到vs 6.0(95%CI:1.1-10.9)个月,χ^(2)=9.870,P<0.05];PCD方案中非高危细胞遗传学异常患者的PFS和OS也均显著高于高危细胞遗传学异常患者[PFS:9.0(95%CI:6.2-11.8)个月vs 6.0(95%CI:5.4-6.6)个月,χ^(2)=14.396,P<0.05;OS:未达到vs 11.0(95%CI:6.4-15.6)个月,χ^(2)=7.471,P<0.05]。结论:泊马度胺为主的方案治疗RRMM具有较好的临床效果,且安全性良好。 展开更多
关键词 多发性骨髓瘤 复发难治 泊马度胺 临床效果
原文传递
上一页 1 2 191 下一页 到第
使用帮助 返回顶部